CFO
IOL Chemicals and Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Pardeep Kumar Dhamna is recorded as CFO at IOL Chemicals and Pharmaceuticals Limited. Pardeep Kumar Dhamna has spoken on 3 earnings calls across 1 company, most recently for IOL Chemicals and Pharmaceuticals Limited on November 2, 2026. IOL Chemicals and Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“I will now take you through the financial performance of the company for the second quarter and first half year of financial year 2021.”
“I will now take you through the financial performance of the company. For that, you are not friends. During quarter 1 of financial year 27, the company reported revenue from operation rupees 756 CR as compared to 551 growth in quarter 1 of financial year 26, resisting a year-on-year growth of 37 percentage.”
“I will now share the financial performance for the quarter and full year, following which we will open the floor for questions and answers. During Q4 of 1926, the company reported a strong top-line performance with revenue from operation of Rs.600.”
IOL Chemicals and Pharmaceuticals Limited
CFO
Transcript header (unverified)
IOL Chemicals and Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call for the Quarter Ended September 30, 2026
IOL Chemicals and Pharmaceuticals Limited
Earnings Call for the Quarter Ended June 30, 2026
IOL Chemicals and Pharmaceuticals Limited
Earnings Call for the Quarter Ended March 31, 2026
IOL Chemicals and Pharmaceuticals Limited
